MUC1 and MUC2 in Pancreatic Neoplasia

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2004 Apr 29

PMID 15113850

Citations 56

Authors

E Levi

D S Klimstra

A Andea

O Basturk

N V Adsay

Affiliations

Soon will be listed here.

Abstract

MUCs are glycoproteins with various roles in homeostasis and carcinogenesis. Among other actions, MUC1 may inhibit cell-cell and cell-stroma interactions and function as a signal transducer, participating in cancer progression. In contrast, MUC2 is normally found only in goblet cells, where it contributes to the protective barrier function of these cells. Recently, a tumour suppressor role has been demonstrated for MUC2, and both MUC1 and MUC2 appear to have important roles in pancreatic neoplasia. MUC1 appears to be a marker of aggressive phenotype and may facilitate the vascular spread of carcinoma cells. In contrast, MUC2 is rarely detectable in aggressive pancreatic tumours, but is commonly expressed in intraductal papillary mucinous neoplasms (IPMNs), which are rare, indolent tumours, in intestinal IPMNs, and in indolent colloid carcinomas. MUC2 appears to be not only a marker of this indolent pathway, but also partly responsible for its less aggressive nature. Thus, in pancreatic neoplasia, MUC1 and MUC2 have potential diagnostic and prognostic value as markers of aggressive and indolent phenotypes, respectively, and have potential as therapeutic targets.

Citing Articles

Subtype-associated complexity and prognostic significance of the NLRP3 inflammasome landscape in pancreatic neoplasms.

Nemeth K, Mezei E, Voros J, Borka K, Pesti A, Kenessey I J Pathol Clin Res. 2025; 11(2):e70019.

PMID: 39969214 PMC: 11837281. DOI: 10.1002/2056-4538.70019.

MUC1 expression is associated with ST3GAL2 and negatively correlated with the androgen receptor in castration-resistant prostate cancer.

Nakanishi S, Suda T, Tanaka K, Yonamine T, Numahata K, Sugawa A Glycoconj J. 2024; 41(6):381-394.

PMID: 39718721 PMC: 11735536. DOI: 10.1007/s10719-024-10173-8.

An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas.

Moris D, Liapis I, Gupta P, Ziogas I, Karachaliou G, Dimitrokallis N Cancers (Basel). 2024; 16(22).

PMID: 39594780 PMC: 11593033. DOI: 10.3390/cancers16223825.

Protective Effect of IgY Embedded in W/O/W Emulsion on LPS Enteritis-Induced Colonic Injury in Mice.

Wang Z, Ye R, Xu Z, Zhang S, Liu C, Zhu K Nutrients. 2024; 16(19).

PMID: 39408328 PMC: 11479051. DOI: 10.3390/nu16193361.

Bile Acids in Pancreatic Carcinogenesis.

Sharma B, Twelker K, Nguyen C, Ellis S, Bhatia N, Kuschner Z Metabolites. 2024; 14(7).

PMID: 39057671 PMC: 11278541. DOI: 10.3390/metabo14070348.

References

Adsay N, Merati K, Andea A, Sarkar F, Hruban R, Wilentz R . The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002; 15(10):1087-95. DOI: 10.1097/01.MP.0000028647.98725.8B. View

Adsay N . Intraductal papillary mucinous neoplasms of the pancreas: pathology and molecular genetics. J Gastrointest Surg. 2002; 6(5):656-9. DOI: 10.1016/s1091-255x(02)00057-4. View

Taylor-Papadimitriou J, Burchell J, Plunkett T, Graham R, Correa I, Miles D . MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia. 2002; 7(2):209-21. DOI: 10.1023/a:1020360121451. View

Yeo C . Intraductal papillary mucinous neoplasms of the pancreas. Adv Surg. 2002; 36:15-38. View

Ookawa K, Kudo T, Aizawa S, Saito H, Tsuchida S . Transcriptional activation of the MUC2 gene by p53. J Biol Chem. 2002; 277(50):48270-5. DOI: 10.1074/jbc.M207986200. View

Almeida R, Silva E, Santos-Silva F, Silberg D, Wang J, de Bolos C . Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol. 2002; 199(1):36-40. DOI: 10.1002/path.1246. View

Walker M . Is intestinal metaplasia of the stomach reversible?. Gut. 2002; 52(1):1-4. PMC: 1773527. DOI: 10.1136/gut.52.1.1. View

Akyurek N, Akyol G, Dursun A, Yamac D, Gunel N . Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract. 2002; 198(10):665-74. DOI: 10.1078/0344-0338-00318. View

Yamamoto H, Bai Y, Yuasa Y . Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun. 2003; 300(4):813-8. DOI: 10.1016/s0006-291x(02)02935-2. View

10.

Eda A, Osawa H, Satoh K, Yanaka I, Kihira K, Ishino Y . Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol. 2003; 38(1):14-22. DOI: 10.1007/s005350300001. View

11.

Tollefson M, Libsch K, Sarr M, Chari S, DiMagno E, Urrutia R . Intraductal papillary mucinous neoplasm: did it exist prior to 1980?. Pancreas. 2003; 26(3):e55-8. DOI: 10.1097/00006676-200304000-00023. View

12.

Tamada S, Goto M, Nomoto M, Nagata K, Shimizu T, Tanaka S . Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int. 2003; 52(11):713-23. DOI: 10.1046/j.1440-1827.2002.01414.x. View

13.

Conio M, Lapertosa G, Blanchi S, Filiberti R . Barrett's esophagus: an update. Crit Rev Oncol Hematol. 2003; 46(2):187-206. DOI: 10.1016/s1040-8428(02)00123-3. View

14.

Adsay N, Merati K, Nassar H, Shia J, Sarkar F, Pierson C . Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of.... Am J Surg Pathol. 2003; 27(5):571-8. DOI: 10.1097/00000478-200305000-00002. View

15.

Oren M . Decision making by p53: life, death and cancer. Cell Death Differ. 2003; 10(4):431-42. DOI: 10.1038/sj.cdd.4401183. View

16.

Fischer H, Zhou H . [Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Review and individual findings]. Pathologe. 2003; 24(3):196-203. DOI: 10.1007/s00292-003-0617-x. View

17.

Lee M, Lee H, Kim W, Choi Y, Yang M . Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003; 16(5):403-10. DOI: 10.1097/01.MP.0000067683.84284.66. View

18.

Li Y, Chen W, Ren J, Yu W, Li Q, Yoshida K . DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol Ther. 2003; 2(2):187-93. DOI: 10.4161/cbt.2.2.282. View

19.

Caderni G, Femia A, Giannini A, Favuzza A, Luceri C, Salvadori M . Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res. 2003; 63(10):2388-92. View

20.

van de Bovenkamp J, Korteland-Van Male A, Warson C, Buller H, Einerhand A, Ectors N . Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2. Histopathology. 2003; 42(6):555-65. DOI: 10.1046/j.1365-2559.2003.01619.x. View